Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction of aluminium contact allergy during Alutard SQ hyposensitisation therapy
2007-003000-35Phase 4Active
- Sponsor
- Department of Occupational and Environmental Dermatology, Skåne University Hospital
- Start
- Jun 2007
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of alutard-sq in allergy (2 arms), sponsored by Department of Occupational and Environmental Dermatology, Skåne University Hospital. Primary endpoint: Positive aluminium patch test. Started Jun 2007; status: active.
02
Drugs
alutard-sq
03
Conditions
allergy
Beyond the preview
Go deeper on 2007-003000-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003000-35.